Option chain shows key data for Forte Biosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Forte Biosciences.

Forte Biosciences (NASDAQ:FBRX) Stock, Option Chain

FORTE BIOSCIENCES INC

Forte Biosciences

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

News

FBRX

Forte Biosciences shares are trading lower by 13.6% Monday afternoon. The company announced plans for the periodic resale of up to 9.5 million common stock shares by selling stockholders.

Why Forte Biosciences (FBRX) Stock Is Trading Lower

Movers

Forte Biosciences Inc. (NASDAQ: FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102. Here&#39;s what you need to know.

Forte Biosciences Shares Are Soaring Today: What&#39;s Going On?

Crude-oil-4-logo

Earnings

Long Ideas

Intraday Update

Markets

Trading Ideas

PRFX

SOAR

XTKG

Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results

Forte Biosciences Inc

Press Releases

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Forte Biosciences to Host R&D Day December 3, 2024

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Aligos Therapeutics

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

BeyondSpring

Celularity

CytomX Therapeutics

Fortress Biotech

Gain Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Immix Biopharma

Immuneering Corporation - Class A Common Stock

Immuneering

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kronos Bio

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

MAIA Biotechnology

Metagenomi

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

PDS Biotechnology Corporation - Common Stock

Comments

Forte Biosciences

Forte Biosciences (FBRX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga